Service Description

This medical weight loss protocol combines Ozempic (Semaglutide), a clinically licensed GLP-1 agonist, with fat-burning amino acids to facilitate safe and sustainable fat loss. Ozempic modulates hunger and insulin sensitivity, whilst amino acids help to maintain lean muscle mass while losing weight. This treatment, given over three months, promotes metabolic reset, decreases cravings, and boosts energy levels. Patients frequently experience considerable inch loss, particularly in stubborn places. This treatment is ideal for patients experiencing weight plateaus or insulin resistance, and it is closely monitored by medical professionals for safety, efficacy, and personalised adjustments.